Vivani Medical (VANI) Shares Outstanding (2014 - 2026)
Vivani Medical (VANI) posted quarterly Shares Outstanding (Entity) of $84.6 million for Q1 2026, up 42.88% year-over-year from $59.2 million in Q1 2025, and up 35.68% quarter-over-quarter from $62.4 million in Q4 2025.
Vivani Medical (VANI) Shares Outstanding (2014 - 2026) Analysis & Trends
Vivani Medical's Shares Outstanding (Entity) history runs 13 years deep, the most recent figure standing at $84.6 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 42.88% year-over-year to $84.6 million; the TTM figure through Mar 2026 stood at $84.6 million (up 42.88% YoY), while the FY2025 annual figure was $62.4 million, up 113373.75% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $84.6 million, up from $62.4 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $84.6 million in Q1 2026, with the low at $13136.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $54981.0 (2024), against an average of $28.7 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) sank 99.86% in 2022, then soared 386585.44% in 2023.
- Vivani Medical's Shares Outstanding (Entity) stood at $38241.0 in 2022, then jumped by 33.45% to $51031.0 in 2023, then climbed by 7.74% to $54981.0 in 2024, then surged by 113373.75% to $62.4 million in 2025, then jumped by 35.68% to $84.6 million in 2026.
- Business Quant data shows VANI's Shares Outstanding (Entity) at $84.6 million in Q1 2026, $62.4 million in Q4 2025, and $61.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 87.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 87.09 Mn |
| Mar 31, 2026 | 81.27 Mn |
| Dec 31, 2025 | 62.39 Mn |
| Sep 30, 2025 | 59.71 Mn |
| Jun 30, 2025 | 59.24 Mn |
| Mar 31, 2025 | 59.24 Mn |
| Dec 31, 2024 | 54,981.00 |
| Sep 30, 2024 | 55.25 Mn |
| Jun 30, 2024 | 55.02 Mn |
| Mar 31, 2024 | 52,202.00 |
| Dec 31, 2023 | 50,853.00 |
| Sep 30, 2023 | 50,837.00 |
| Jun 30, 2023 | 50.80 Mn |
| Mar 31, 2023 | 50,755.00 |
| Dec 31, 2022 | 38,241.00 |
| Sep 30, 2022 | 37,965.00 |
| Jun 30, 2022 | 13,136.00 |
| Mar 31, 2022 | 13,136.00 |
| Dec 31, 2021 | 10.94 Mn |
| Sep 30, 2021 | 13.14 Mn |